WallStreetZenWallStreetZen

NYSEMKT: NSRX
Nasus Pharma Ltd Stock Ownership - Who owns Nasus Pharma?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Nasus Pharma Ltd insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when NSRX insiders and whales buy or sell their stock.

NSRX Shareholders

What type of owners hold Nasus Pharma Ltd stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Morgan Stanley0.02%2,000$15.00kInstitution
Ubs Group Ag0.01%1,241$9.31kInstitution

1 of 1

NSRX vs General Drug Manufacturer Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
NSRX0.04%0.00%
MIRA3.33%18.27%Net BuyingNet Buying
SCLX1.39%98.61%
MDCX9.62%44.92%Net Buying
AMRN0.96%16.26%Net Selling
View Top General Drug Manufacturer Stocks

Nasus Pharma Stock Ownership FAQ

Who owns Nasus Pharma?

Nasus Pharma (NYSEMKT: NSRX) is owned by 0.04% institutional shareholders, 0.00% Nasus Pharma insiders, and 99.96% retail investors. Morgan Stanley is the largest individual Nasus Pharma shareholder, owning 2000.00 shares representing 0.02% of the company. Morgan Stanley's Nasus Pharma shares are currently valued at $15.58k.

If you're new to stock investing, here's how to buy Nasus Pharma stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.